Loading chat...

NY A01720

Bill

Status

Introduced

1/14/2025

Primary Sponsor

Linda Rosenthal

Click for details

Origin

Assembly

2025-2026 General Assembly

AI Summary

  • Prohibits insurers from requiring or allowing patients to transport ("brown bag") medications from an insurer-designated pharmacy to a physician's office, hospital, or clinic for administration

  • Prohibits insurers from mandating the use of home infusion pharmacies or external infusion sites, though coverage may still be offered as an option

  • Requires insurers to establish formal agreements with healthcare providers before mandating "white bagging" (direct pharmacy-to-provider medication delivery), including at least 90 days' notice before implementation

  • Mandates insurer-designated pharmacies meet specific quality standards: same-day delivery, 24/7 pharmacist/nurse access, cold chain temperature control, national accreditation, drug pedigree documentation, and FDA risk mitigation compliance

  • Exempts from insurer-designated pharmacy requirements medications requiring sterile compounding by providers or patient-specific dosing based on same-day lab results

  • Requires site-neutral payment to providers that includes costs for medication intake, storage, and disposal

Legislative Description

Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy; prohibits certain "brown bagging" and "white bagging" policies regarding pharmacy provided medications.

Last Action

referred to insurance

1/7/2026

Committee Referrals

Insurance1/14/2025

Full Bill Text

No bill text available